Status:
UNKNOWN
Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon
Lead Sponsor:
Laboratório Teuto Brasileiro S/A
Conditions:
Chronic Venous Insufficiency
Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The objective is to evaluate the effectiveness of the safety of Daflon in decreasing symptoms resulting from chronic venous insufficiency when compared with Daflon.
Detailed Description
"A clinical multicenter, phase III, prospective, randomized, double-blind, comparative study to evaluate the efficacy and tolerability of Venaflon use in reducing the symptoms caused by chronic venous...
Eligibility Criteria
Inclusion
- Patients of any ethnic group, both sexes and aged at least 18 years and a maximum of 65 years
- Women and men of childbearing age who agree to use acceptable contraception throughout the study.
- Be patient with chronic venous insufficiency of lower limbs varicose comDiagnostico clinical CEAP 0-3 by CEAP
- Presence of at least 23 symptoms (pain, heaviness and discomfort, symptoms of heat and burning sensation in the legs) in the lower limbs, with a score equal to or greater than 4, as measured by visual analog scale
- Being the 7 days without any medication or treatment related to the venous system.
- Patients able to make proper use of medication
- Patients who consent to participate in the study by signing the Instrument of Consent.
Exclusion
- Pregnant or breastfeeding women
- Women who are breastfeeding
- Women and men of childbearing age who do not accept to use acceptable contraception throughout the study
- Patients under 18 or over 65 years
- Patients with a history of hypersensitivity to any component of the formula
- Presence of signs and symptoms of different conditions of venous disease to justify the pain or swelling
- Use of elastic compression in the last two weeks
- Venous obstruction of the lower limbs
- Patients who have previously used or Venaflon Daflon and did not benefit;
- Deep vein thrombosis in the last 6 months before entering the study;
- Use of diuretics in the last 4 weeks
- Previous venous surgery
- Patients with renal and liver failure
- Patients with gastritis or gastric ulcer
- Patients with blood clotting disorders
- Any condition which in the opinion of the physician researcher is significant and can make the patient unsuitable for study or you can place it under additional risk
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2012
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT01477281
Start Date
February 1 2012
End Date
August 1 2012
Last Update
November 22 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.